COVI Study

COVI study has been designed to compare the safety and effectiveness of the CornerLocTM SI Joint Stabilization System to intra-articular sacroiliac joint steroid injection in patients with refractory sacroiliac joint dysfunction.

Sponsor: CornerLoc

Primary  Investigator: Dr. Michael Esposito

TARGET Study  

TARGET study is a post-approval study to evaluate Targeted Spinal Cord Stimulation (DRG) for the management of moderate to severe chronic intractable pain of the lower limbs due to Chronic Regional Pain Syndrome (CRPS) types 1 and 2.
Post-market follow up study to show how well the SCS works.

Sponsor: Abbott

Primary Investigator: Dr. Michael Esposito

For more info please visit


The purpose of this multi-center, prospective, post-market observational study is to assess the effectiveness of HF10 therapy delivered to the spinal cord in subjects with chronic, intractable neuropathic pain of the truck and/or limbs and who have also previously failed treatment with a traditional SCS system including dorsal root ganglion (DRG) stimulation (either trail or permanent implant).

Sponsor: Nevro

Primary Investigator: Dr. Michael Esposito



The purpose of this post-market surveillance is to gather evidence documenting the performance and clinical outcomes associated with the treatment of moderate degenerative lumbar spinal stenosis using Superion Indirect Decompression System (IDS).

Sponsor: Vertiflex

Primary Investigator: Dr. Ashish Udeshi

Product Surveillance Registry (PSR)

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of market-released products for their intended use (Spinal cord stimulators and pain pumps).

Sponsor: Medtronic

Primary Investigator: Dr. Ashish Udeshi

For more info please visit

Patient Retrospective Outcomes (PRO)

The primary objective of this study is to characterize real-world clinical outcomes with the use of Boston Scientific or acquired systems for treatment of chronic pain using retrospective review of de-identified patient records.

Sponsor: Boston Scientific

Primary Investigator: Dr. Michael Esposito

For more study information, please email our Clinical Research Coordinator Theresa Arandia at  You may also call 321-784-8211 ext 6241138.